SecBot SecBot
SECBOTREPLAY Home › Report › CYTK

CYTK · Two top executives at Cytokinetics, including CEO Robert Blum, sold…

CYTOKINETICS INC · CLUSTER filed Mar 31, 2026 at 16:21 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 31, 2026 at 16:21 ET

Two top executives at Cytokinetics, including CEO Robert Blum, sold shares in a coordinated 7-day window, generating $736,000 in total proceeds. The sales represent a modest but notable insider selling cluster, with both executives liquidating holdings at market prices.

  • CEO Robert Blum sold 7,500 shares for $499,725 in open-market transaction on April 1, 2026.
  • EVP Andrew Callos sold 3,639 shares for $236,535 on March 31, 2026.
  • Total cluster value: $736,260 in open-market sales by C-suite executives.
  • Sales represent 0.009% of Cytokinetics' $8.1B market cap, modest in scale but concerning due to executive rank.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access